Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Neurontin (Gabapentin) Oral Solution, Capsules & Tablets
Company:  Parke-Davis
Application No.:  021216/020235S015/020882S002/021129S005
Approval Date: 10/12/2000


Date created: May 062004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.